chronic granulomatous disease

Successful Management of Spondylodiscitis Caused by Aspergillus nidulans: A Case Report and Literature Review

mycolabadmin

A 59-year-old man with a weakened immune system developed a serious fungal infection of his spine caused by Aspergillus nidulans, a type of mold. The infection was diagnosed through imaging tests and laboratory cultures from a biopsy of the affected vertebrae. Treatment with an antifungal medication called voriconazole for six months successfully cleared the infection without requiring surgery, offering hope for managing this rare and previously often-fatal condition.

Beyond division and morphogenesis: Considering the emerging roles of septins in plasma membrane homeostasis and cell wall integrity in human fungal pathogens

mycolabadmin

Septins are protein structures inside fungal cells that help them divide and maintain their outer layers. This review explains how these proteins play crucial roles in fungal infections by helping pathogens survive stress conditions and respond to host defenses. By understanding how septins work, scientists might develop new antifungal medications that target these proteins to fight stubborn fungal infections.

Fungal Infections – a Stealthy Enemy in Patients with Chronic Granulomatous Disease: a 28-years’ Experience from North India

mycolabadmin

Patients with chronic granulomatous disease (CGD), a rare immune system disorder, are highly susceptible to serious fungal infections. This study of 99 patients over 28 years found that 40% developed fungal infections, mostly caused by Aspergillus fungi affecting the lungs. These infections were life-threatening, with over half the infected patients dying despite aggressive treatment with antifungal medications. Doctors need to screen for fungal infections early, even in patients without obvious symptoms, and treat infants and males more aggressively.

Rasamsonia argillacea brain abscess in a lung transplant recipient: an unexpected infection by an unusual fungal pathogen

mycolabadmin

A 65-year-old woman who received a lung transplant developed a serious brain infection caused by a rare fungus called Rasamsonia argillacea. Doctors initially struggled to identify this unusual fungus and treated her with multiple antifungal medications, but the infection proved difficult to control because the fungus was resistant to common antifungal drugs. Investigations revealed that the patient had an undiagnosed immune system disorder called chronic granulomatous disease, which made her vulnerable to this rare infection. Despite aggressive treatment including surgery and powerful antifungal medications, the patient’s condition worsened and she eventually passed away.

Rasamsonia argillacea brain abscess in a lung transplant recipient: an unexpected infection by an unusual fungal pathogen

mycolabadmin

A 65-year-old woman who received a lung transplant developed a rare and serious brain infection caused by an unusual fungus called Rasamsonia argillacea. The infection was difficult to diagnose because it looks similar to more common molds under the microscope. During the investigation of this unexpected infection, doctors discovered that the patient had a rare genetic disorder affecting her immune system that had never been diagnosed. This case highlights how unusual infections can reveal hidden immune system problems.

Appearance of Environment-Linked Azole Resistance in the Aspergillus fumigatus Complex in New Zealand

mycolabadmin

Researchers in New Zealand have discovered that a dangerous fungus called Aspergillus fumigatus is developing resistance to commonly used antifungal medications. Unlike previous cases where the resistance came from medical treatment, this new resistance appears to come from environmental exposure, possibly through garden fungicides that people can buy at garden centers. The study found that people, especially lung transplant patients, may be acquiring these resistant fungal strains from their surroundings rather than from hospitals, highlighting the need for better monitoring of agricultural fungicide use.

Consecutive non-Aspergillus Fungal Invasive Infections in Chronic Granulomatous Disease: Data from the French National Reference Center for Primary ImmunoDeficiencies and literature review

mycolabadmin

This study examines rare fungal infections in patients with Chronic Granulomatous Disease, a genetic disorder affecting the immune system. Researchers found that these patients develop various unusual fungal infections despite taking preventive antifungal medications. The infections are difficult to diagnose, often requiring surgical procedures, but can sometimes be cured through stem cell transplantation combined with intensive antifungal treatment.

First case of invasive Rasamsonia argillacea in a child with chronic granulomatous disease in Qatar

mycolabadmin

A 16-year-old girl with a rare immune system disorder called chronic granulomatous disease developed a serious fungal infection caused by Rasamsonia argillacea, a fungus that is not commonly seen in clinical practice. The infection presented as a painful collection in her chest wall that required surgery and multiple antifungal medications. This is the first reported case of this particular fungal infection in the Arabian Peninsula, and successful treatment required a combination of drugs chosen based on laboratory testing of the fungus’s resistance patterns.

Consecutive non-Aspergillus Fungal Invasive Infections in Chronic Granulomatous Disease: Data from the French National Reference Center for Primary ImmunoDeficiencies and literature review

mycolabadmin

This study examines rare but serious fungal infections in patients with chronic granulomatous disease, a genetic immune disorder. Researchers analyzed 122 cases of non-Aspergillus fungal infections from French hospitals and published literature, finding that these infections often occur despite preventive antifungal medications and are challenging to diagnose. The infections were found in the lungs most commonly but could spread to bones, brain, and other organs, with treatments including antifungal drugs, surgery, and in some cases bone marrow transplants.

Disease: chronic granulomatous disease